Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues86
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review77
Hemostasis from Bench to Bedside: The History of Three Successful Stories of Translational Medicine53
46
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review44
Pregnancy Related Venous Thromboembolism-Associated with HIV Infection and Antiretroviral Therapy44
Mechanical Heart Valves, Pregnancy, and Bleeding: A Systematic Review and Meta-Analysis37
Three-Dimensional Human Neural Stem Cell Models to Mimic Heparan Sulfate Proteoglycans and the Neural Niche37
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards30
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?30
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States29
Upper Extremity Deep Vein Thrombosis: Current Knowledge and Future Directions27
Cardiovascular Oncology: The Need for a Multidisciplinary Approach24
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease22
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy22
22
Erratum: Microparticles: An Alternative Explanation to the Behavior of Vascular Antiphospholipid Syndrome22
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications22
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review21
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy20
Response to “Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease”19
19
Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders19
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life19
Glanzmann Thrombasthenia 10 Years Later: Progress Made and Future Directions19
Platelet-Type von Willebrand Disease: Complex Pathophysiology and Insights on Novel Therapeutic and Diagnostic Strategies19
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications18
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders18
Antiphospholipid Syndrome in Patients with Venous Thromboembolism18
A Historical Perspective on the Reversal of Anticoagulants18
Cerebral Venous Thrombosis18
Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients17
17
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis17
The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition17
Altered Fibrinolysis during and after Surgery16
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization16
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III15
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis15
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting15
Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease14
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)14
Dedication to Santa Maria Favaloro (1926–2022)14
The Role of CD36/GPIV in Platelet Biology13
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature13
Sticky Platelet Syndrome Revisited?13
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome13
Inhibitors of Polyphosphate and Neutrophil Extracellular Traps13
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review13
Bleeding Scoring Systems in Neonates: A Systematic Review13
Russell Viper Venom: A Journey from the Bedside to the Bench and Back to the Bedside13
The Role of Thromboelastography during the Management of Postpartum Hemorrhage: Background, Evidence, and Practical Application12
Heparin: The Journey from Parenteral Agent to Nasal Delivery12
What Role Does Microthrombosis Play in Long COVID?12
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II12
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook12
Editorial Compilation XIV12
Erratum: Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden12
Trousseau's Syndrome in 19th Century Qing Dynasty Paintings of Breast Tumors: Early Insights into Cancer and Thrombosis Risk12
Mean Platelet Volume Predicts Severe COVID-19 Illness11
The Impact of Emotional Responses on Female Reproduction: Fibrinolysis in the Spotlight11
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk11
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice11
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis11
Catastrophic Thrombosis: A Narrative Review11
Substrates, Cofactors, and Cellular Targets of Coagulation Factor XIa11
Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis11
Effect of Heparanase and Heparan Sulfate Chains in Hemostasis11
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?11
Role of Platelets and Their Interaction with Immune Cells in Venous Thromboembolism11
Fibrin Clot Properties in Cancer: Impact on Cancer-Associated Thrombosis11
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr10
Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents10
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies10
Thromboembolic Complications in Takotsubo Cardiomyopathy10
The History of Factor XIII Deficiency10
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases10
Novel Insights into Heterozygous Factor XIII Deficiency9
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review9
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey9
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance9
The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System9
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients9
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants9
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions9
Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 versus Vaccine-induced Immune Thrombocytopenia and Thrombosis in the United Kingdom9
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease9
Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies9
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years9
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method8
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease8
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis8
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review8
Recent Advances in Thrombosis and Hemostasis—Part VII8
8
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review8
Venous Thromboembolism among Critically Ill Children: A Narrative Review8
Is Vitamin D Deficiency Prothrombotic? A Systematic Review8
Development of Molecules Antagonizing Heparan Sulfate Proteoglycans8
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review8
The ART of Thromboprophylaxis in the Prevention of Gestational Venous Thromboembolism8
Gastrointestinal Bleeding in Congenital Bleeding Disorders8
8
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years8
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series8
Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?8
8
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)8
Erratum: Septic Pulmonary Embolism. A Contemporary Profile7
Platelet Function Testing: Update and Future Directions7
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage7
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment7
Hereditary Hemorrhagic Telangiectasia: On the Brink of a New Treatment Era?7
Inflammation and Coagulation in Neurologic and Psychiatric Disorders7
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program7
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia7
Thrombin: A Pivotal Player in Hemostasis and Beyond7
Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology7
Arterial Thrombosis in Cancer Patients: An Update7
Platelet Activation and Thrombosis in COVID-197
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation7
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles7
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-197
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies7
Development of a Coagulation Disorders Unit6
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature6
Blood Rheology and Hemodynamics6
A Critical Reappraisal of the Bleeding Time6
Platelet Physiology6
Heparin and Posttraumatic Stress Disorder6
Testing for Lupus Anticoagulants6
Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part I6
6
Description of an In Vitro Platelet Function Analyzer—PFA-100™6
The Role of Myeloid Cells in Thromboinflammatory Disease6
Thrombophilia Screening: Not So Straightforward6
6
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions6
Contraceptives and Thrombosis: An Intertwined Revolutionary Road6
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review6
Platelets: Physiology and Biochemistry6
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice6
Factor XII Structure–Function Relationships6
0.35485005378723